Venetoclax Plus Isatuximab and Dexamethasone

A Phase 2 Study of Venetoclax in Combination With Isatuximab and Dexamethasone for Relapsed/Refractory Multiple Myeloma Patients With t(11;14)

What's the purpose of the trial?

A phase 2 study of venetoclax in combination with isatuximab and dexamethasone for relapsed/refractory multiple myeloma patients with t(11;14)
Trial status

Accepting patients

Phase
Phase 2
Enrollment
39
Last Updated
6 months ago

Participating Centers

There are 2 centers participating in this trial. Enter a location below to find the closest center.

Experimental Treatments

Learn more about the experimental treatments being evaluated in this clinical trial.

  • Dexamethasone
  • Isatuximab
  • Venetoclax

Arms / Cohorts

Explore eligibility, treatments and learn more about potential cohorts.

Not yet accepting

Venetoclax + Isatuximab + Dexamethasone

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print this trial to share with your doctor.

(888) 828-2206

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.